CAS RN: 1422496-61-4
tert-butyl 2-oxa-6-azaspiro[3.4]octan-8-ylcarbamate
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250704
250mg / 1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1422496-61-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
1422496-61-4 / tert-butyl N-(2-oxa-7-azaspiro[3.4]octan-5-yl)carbamate
Standard CAS: 1422496-61-4
Multi CAS: No
Basic Information
copy
CAS
1422496-61-4 copy
Multi CAS
No copy
Molecular Formula
C11H20N2O3 copy
Molecular Weight
228.290000 copy
Exact Mass
228.147393 copy
SMILES
CC(C)(C)OC(=O)NC1CNCC12COC2 copy
InChI
InChI=1S/C11H20N2O3/c1-10(2,3)16-9(14)13-8-4-12-5-11(8)6-15-7-11/h8,12H,4-7H2,1-3H3,(H,13,14) copy
InChIKey
XRGGCKIYCRHBHJ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Fraction Csp3
0.91 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
59.28 copy
TPSA
59.59 copy
LogP / Solubility
WLOGP
0.5 copy
MLOGP
0.44 copy
XLogP3
0.1 copy
Consensus LogP
0.35 copy
Log S (ESOL)
-1.5 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.79 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.68 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.76 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy